IMR Press / CEOG / Volume 47 / Issue 2 / DOI: 10.31083/j.ceog.2020.02.5043
Submit to CEOG
Cite this article
Nanoparticles: Properties, applications and toxicities
28
Downloads
1
Citations
127
Views
Journal Browser
Volume | Year
Issue
Search
Forthcoming Issue
Current Issue
All
Announcements
    Open Access Original Research
    Pregnancy outcomes and risk factors in pregnant women with systemic lupus erythematosus
    Li Li Zhang1, Hua Shu2,*, Shuai Zhang3, Tian Tian Wang3, Lan Lan Zhang4
    Show Less
    1 Department of Rheumatology Immunologys, Affiliated Hospital of Jining Medical College, Jining, P.R. China
    2 Department of Obstetrics, Affiliated Hospital of Jining Medical College, Jining, P.R. China
    3 Department of Infection, Jining Infectious Disease Hospital, Jining, P.R. China
    4 Department of Internal Medicine, Jining Psychiatric Hospital, Jining, P.R. China
    shuhuajn@126.com (HUA SHU)
    Clin. Exp. Obstet. Gynecol. 2020, 47(2), 189–193; https://doi.org/10.31083/j.ceog.2020.02.5043
    Published: 15 April 2020
    Copyright: © 2020 Zhang et al. Published by IMR Press.
    This is an open access article under the CC BY-NC 4.0 license (https://creativecommons.org/licenses/by-nc/4.0/).
    View Full-text
    Download PDF
    Figures
    Cite
    Abstract
    Objective: To analyze the pregnancy outcomes and risk factors in pregnant women with systemic lupus erythematosus (SLE), for providing a reference for the clinical diagnosis and treatment of the SLE. Materials and Methods: Seventy-eight SLE patients with 82 pregnancies were enrolled in this study. The general information of patients, maternal history data, clinical symptoms, and laboratory examination data one to three months before pregnancy, during pregnancy, at delivery and after childbirth, drug treatment, and pregnancy outcomes were collected. The single factor and logistic regression analyses of the risk factors related to SLE with deterioration and fetal loss were performed. Results: The single-factor analysis showed that there was significant difference in complement 3, 24-hour urinary protein, anti-dsDNA antibody, anti-CL antibody, pre-pregnancy prednisone dose, and SLE disease activity index (SLEDAI) between SLE with deterioration group and SLE without deterioration group, respectively (p < 0.05 or p < 0.01), with significant difference in complement 3, combined antiphospholipid syndrome (APS), SLEDAI, and SLE deterioration during pregnancy between fetal loss group and live birth group, respectively (p < 0.01). The multi-factor regression analysis showed that, the complement 3 and SLEDAI were the main risk factors of SLE with deterioration during pregnancy, and the combined APS and SLEDAI were the main risk factors of fetal loss. Conclusion: The pregnancy has a high risk in women with SLE. The complement 3 and SLEDAI are the main risk factors of SLE with deterioration during pregnancy, and the combined APS and SLEDAI are the main risk factors of fetal loss. The reasonable and effective strategies should be formulated based on these factors, in order to reduce the risk of adverse pregnancy outcomes.
    Keywords
    Systemic lupus erythematosus
    Pregnancy
    Outcomes
    Risk factors
    Figures
    Figure 1.
    Previous article in this issue
    Next article in this issue
    Share
    Back to top
    Clin. Exp. Obstet. Gynecol. Print ISSN 0390-6663 Electronic ISSN 2709-0094
    Disclaimer
    We use cookies on our website to ensure you get the best experience.
    Read more about our cookies here
    Accept